APIs/HPAPIs
The micronization of APIs and HPAPIs is our GMP core competency, supported by three manufacturing sites and 17 dedicated micronization rooms. We offer a broad containment range, from OEB 1 (≥100 µg/m³) up to OEB 4B (≥50 ng/m³), ensuring safe handling of high‑potency compounds. Our flexible asset base includes six rigid isolators (0.5–150 kg batch size), seven semi‑closed systems, and four open units, with jet mills ranging from 50 to 500 mm and medium-large scale mechanical mills. We operate dedicated suites for steroids (and sexual hormones) and are equipped to process non‑beta‑lactam antibiotics, delivering reliable, scalable, and compliant micronization solutions.